Professor Dame Sally Davies, Chief Medical Officer, unveiled the plaque in a reception held on the lawns of the CCVTM, following an afternoon symposium where a number of the Centre’s top researchers presented their work and reviewed their achievements over the past decade.
Home to the University’s clinical vaccine development programmes, and Oxford’s base for several outstandingly successful infectious disease research programmes in Africa and Asia, speakers at the CCVTM symposium included Professors Nick Day, Director of the The Mahidol Oxford Tropical Medicine Research Unit in Thailand, Andrew Brent from the KEMRI-Wellcome Trust Research Programme in Kenya, Adrian Hill from the Jenner Institute, Andrew Pollard from the Oxford Vaccine Group, and Jeremy Farrar Director of the Oxford Clinical Research Unit in Vietnam.
At the reception following the symposium, Professor Dame Sally Davies, addressed a large gathering of researchers and high profile guests from the University, the NHS, and key funding agencies, charging her glass to Professor Richard Moxon’s vision as she unveiled the plaque in his honour.
“It’s wonderful to see the range of science that has happened here in Oxford,” Davies said, addressing Professor Moxon.
“You were ahead of your time, you made this (CCVTM) happen and you continue to make it happen; I am delighted to unveil this plaque in your honour.”
Richard Moxon said he was “deeply honoured” by the gesture but also paid tribute to the large team of people within the Collegiate University who made his vision a reality.
“I feel a truly great honour in this, but it has involved huge numbers of people,” Moxon said. “We had a wonderful working group, and to all of those who have made it happen I want to say, truly, thank you.”